Hong Kong Eye Hospital; CUHK Eye Centre
About Hong Kong Eye Hospital; CUHK Eye Centre
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Clinical Trials at Hong Kong Eye Hospital; CUHK Eye Centre
During the past decade, Hong Kong Eye Hospital; CUHK Eye Centre conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on
average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
2018-10-09
2021-08-27
Completed
951
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
2019-03-11
2022-01-07
Completed
658
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema
2020-08-05
2023-08-18
Active, not recruiting
1,479
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion
2021-03-02
2023-06-15
Active, not recruiting
553
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion
2021-03-02
2023-07-13
Active, not recruiting
729
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
2021-04-19
2024-08-09
Active, not recruiting
1,036
A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration
2023-12-29
2026-01-30
Suspended
560
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hong Kong Eye Hospital; CUHK Eye Centre"
#1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hong Kong Eye Hospital; CUHK Eye Centre
According to Clinical.Site data, the most researched conditions in "Hong Kong Eye Hospital; CUHK Eye Centre" are
"Diabetic Macular Edema" (2 trials), "Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials), "Central Retinal Vein Occlusion" (1 trials) and "Hemiretinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Hong Kong Eye Hospital; CUHK Eye Centre" in a lesser frequency.
Clinical Trials Intervention Types at Hong Kong Eye Hospital; CUHK Eye Centre
Most popular intervention types in "Hong Kong Eye Hospital; CUHK Eye Centre" are "Drug" (7 trials), "Procedure" (4 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (5 trials), "Port Delivery System with ranibizumab (PDS)" (1 trials) and "Ranibizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hong Kong Eye Hospital; CUHK Eye Centre
The vast majority of trials in "Hong Kong Eye Hospital; CUHK Eye Centre" are
7 trials for "All" genders.
Clinical Trials Status at Hong Kong Eye Hospital; CUHK Eye Centre
Currently, there are NaN active trials in "Hong Kong Eye Hospital; CUHK Eye Centre".
undefined are not yet recruiting,
undefined are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hong Kong Eye Hospital; CUHK Eye Centre,
1 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hong Kong Eye Hospital; CUHK Eye Centre, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".